Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

BACKGROUND AND PURPOSE Visual hallucinations (VH) and subjective cognitive complaints (SCC) are associated with cognitive impairment (CI) in Parkinson's disease. Our aims were to determine the association between VH and SCC and the risk of CI development in a cohort of patients with Parkinson's disease and normal cognition (PD-NC). METHODS Patients with PD-NC (total score of >80 on the Parkinson's Disease Cognitive Rating Scale [PD-CRS]) recruited from the Spanish COPPADIS cohort from January 2016 to November 2017 were followed up after 2 years. Subjects with a score of ≥1 on domain 5 and item 13 of the Non-Motor Symptoms Scale at baseline (V0) were considered as "with SCC" and "with VH," respectively. CI at the 2-year follow-up (plus or minus 1 month) (V2) was defined as a PD-CRS total score of <81. RESULTS At V0 (n=376, 58.2% males, age 61.14±8.73 years [mean±SD]), the frequencies of VH and SCC were 13.6% and 62.2%, respectively. VH were more frequent in patients with SCC than in those without: 18.8% (44/234) vs 4.9% (7/142), p<0.0001. At V2, 15.2% (57/376) of the patients had developed CI. VH presenting at V0 was associated with a higher risk of CI at V2 (odds ratio [OR]=2.68, 95% confidence interval=1.05-6.83, p=0.0.039) after controlling for the effects of age, disease duration, education, medication, motor and nonmotor status, mood, and PD-CRS total score at V0. Although SCC were not associated with CI at V2, presenting both VH and SCC at V0 increased the probability of having CI at V2 (OR=3.71, 95% confidence interval=1.36-10.17, p=0.011). CONCLUSIONS VH were associated with the development of SCC and CI at the 2-year follow-up in patients with PD-NC.

[1]  Jiu Chen,et al.  Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment , 2021, Frontiers in Neuroscience.

[2]  D. Aarsland,et al.  Parkinson disease-associated cognitive impairment , 2021, Nature Reviews Disease Primers.

[3]  H. Berendse,et al.  Visual hallucinations in Parkinson’s disease are associated with thinning of the inner retina , 2020, Scientific Reports.

[4]  Y. Iguchi,et al.  Risk factors for minor hallucinations in Parkinson's disease , 2020, Acta neurologica Scandinavica.

[5]  Zheyu Xu,et al.  Subjective cognitive Complaints in early Parkinson's disease patients with normal cognition are associated with affective symptoms. , 2020, Parkinsonism & related disorders.

[6]  J. Kulisevsky,et al.  Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease , 2020, European journal of neurology.

[7]  D. Collerton,et al.  Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia , 2020, Frontiers in Neurology.

[8]  J. Trojanowski,et al.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine? , 2020, Movement disorders : official journal of the Movement Disorder Society.

[9]  I. Parees,et al.  The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype , 2020, Neurological Sciences.

[10]  B. Mollenhauer,et al.  Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.

[11]  J. Kulisevsky,et al.  Non‐motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease , 2020, European journal of neurology.

[12]  Jianpin Liu,et al.  Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson’s disease: a Chinese population-based study , 2019, Neurological Sciences.

[13]  I. Parees,et al.  COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation , 2019, European journal of neurology.

[14]  P. Bugalho,et al.  Cognitive complaints in Parkinson’s disease patients: from subjective cognitive complaints to dementia and affective disorders , 2019, Journal of Neural Transmission.

[15]  A. Nieto,et al.  Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study , 2019, Journal of Neurology.

[16]  R. Kliegl,et al.  How to capitalize on a priori contrasts in linear (mixed) models: A tutorial , 2018, Journal of Memory and Language.

[17]  Marios Politis,et al.  Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.

[18]  Yang Pan,et al.  Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease , 2017, Journal of the Neurological Sciences.

[19]  J. Kulisevsky,et al.  COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression , 2016, BMC Neurology.

[20]  D. Chan,et al.  Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients , 2015, Front. Neurol..

[21]  D. Moser,et al.  Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients , 2014, European journal of neurology.

[22]  Y. Sohn,et al.  Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease , 2014, Neurobiology of Aging.

[23]  M. T. Pellecchia,et al.  Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? , 2014, Journal of geriatric psychiatry and neurology.

[24]  J. Kulisevsky,et al.  Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment , 2013, Movement disorders : official journal of the Movement Disorder Society.

[25]  N. Bargalló,et al.  Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. , 2013, Parkinsonism & related disorders.

[26]  S. Landau,et al.  Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4‐year study , 2013, International journal of geriatric psychiatry.

[27]  J. Kulisevsky,et al.  Cognitive impairment and dementia in Parkinson's disease , 2012, Neurobiology of Disease.

[28]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[29]  D. Aarsland,et al.  The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.

[30]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[31]  I. McKeith,et al.  A semi‐structured interview to assess visual hallucinations in older people , 2008, International journal of geriatric psychiatry.

[32]  Jaime Kulisevsky,et al.  Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[33]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[34]  Paolo Barone,et al.  The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[35]  B. Laurent,et al.  The cognitive complaint interview (CCI) , 2006 .

[36]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[37]  A. David,et al.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.

[38]  J. Sanchez-Ramos,et al.  Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.

[39]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.